Physitrack PLC (Nasdaq First North Premier: PTRK) receives order from leading NHS MSK physiotherapy team. The deal is worth £7,949.88 (pre VAT) (approximately 9,169.83 EUR), in annual recurring subscription revenue (ARR)
LONDON, United Kingdom, Monday 27th April 2026– Physitrack PLC today announces a new agreement with a leading NHS MSK physiotherapy team to support the delivery of high-quality public healthcare across the Trust.
The deal further strengthens Physitrack’s presence across the UK Public Healthcare system.
Under the agreement, Physitrack will provide exercise prescription software for up to 51 practitioners, enabling the customer to:
The solution supports patients, practitioners, service and operational leads, through the provision of best in class exercise prescription.
“We are pleased to announce this agreement, which further demonstrates the strength and versatility of the Physitrack platform” said Henrik Molin, CEO and Founder of Physitrack PLC. Building long term customer partnerships through clinical expertise, world-leading technology and behavioural change is part of Physitrack’s DNA. Our platform and support will help increase the efficiency and effectiveness of clinical operations and increase outcomes for patients in the NHS.”